In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Adverum Biotechnologies Inc (NASDAQ: ADVM) closed the day trading at $4.09 down -0.73% from the previous closing price of $4.12. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 0.56 million shares were traded. ADVM stock price reached its highest trading level at $4.16 during the session, while it also had its lowest trading level at $3.9914.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $25. On April 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.H.C. Wainwright initiated its Buy rating on April 30, 2024, with a $30 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 15 ’25 when Soparkar Peter sold 2,960 shares for $2.00 per share. The transaction valued at 5,920 led to the insider holds 39,154 shares of the business.
Seyedkazemi Setareh sold 924 shares of ADVM for $1,848 on May 15 ’25. The CHIEF DEVELOPMENT OFFICER now owns 13,768 shares after completing the transaction at $2.00 per share. On May 15 ’25, another insider, Fischer Laurent, who serves as the CEO, PRESIDENT AND DIRECTOR of the company, sold 9,126 shares for $2.00 each. As a result, the insider received 18,252 and left with 87,488 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADVM now has a Market Capitalization of 90296848 and an Enterprise Value of 153176848.
Stock Price History:
The Beta on a monthly basis for ADVM is 0.86, which has changed by -0.36124033 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, ADVM has reached a high of $6.98, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is -5.92%, while the 200-Day Moving Average is calculated to be 17.84%.
Shares Statistics:
Over the past 3-months, ADVM traded about 628.32K shares per day on average, while over the past 10 days, ADVM traded about 401760 shares per day. A total of 22.00M shares are outstanding, with a floating share count of 13.76M. Insiders hold about 37.66% of the company’s shares, while institutions hold 40.10% stake in the company. Shares short for ADVM as of 1763078400 were 811403 with a Short Ratio of 1.56, compared to 1760486400 on 875370. Therefore, it implies a Short% of Shares Outstanding of 811403 and a Short% of Float of 4.16.
Earnings Estimates
The dynamic stock of Adverum Biotechnologies Inc (ADVM) is currently being evaluated by a team of 4.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.35 and low estimates of -$1.98.
Analysts are recommending an EPS of between -$7.68 and -$8.73 for the fiscal current year, implying an average EPS of -$8.23. EPS for the following year is -$3.58, with 5.0 analysts recommending between -$1.28 and -$8.25.
